Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD)

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD)

Sponsors and Collaborators
Bayer

Contact
Bayer Clinical Trials Contact
clinical-trials-contact@bayerhealthcare.com

Principal Investigator
Bayer Study Director, Bayer

ClinicalTrials.gov Identifier
NCT01412398

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters